
Topical TXA reduces transfusion and blood loss in THA compared to placebo

Topical TXA reduces transfusion and blood loss in THA compared to placebo
Topical application of tranexamic Acid in primary total hip arthroplasty: a randomized double-blind controlled trial
J Arthroplasty. 2014 Dec;29(12):2452-6Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
103 patients scheduled for total hip arthroplasty were randomized to intraoperatively receive the application of 3g tranexamic intra-articularly (IA-TXA), or simply receive saline. The purpose of this study was to evaluate the efficacy of IA-TXA in reducing transfusion rate and blood loss, without increasing the incidence of thromboembolic complications. The results demonstrated a significantly lo...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.